APAC Throat Cancer Diagnostics Market - Industry Trends and Forecast to 2030

Description

List of Tables

The Asia-Pacific throat cancer diagnostics market is projected to register a substantial CAGR of 8.0% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030.

Market Segmentation:

Asia-Pacific Throat Cancer Diagnostics Market, By Product Type (Instruments and Consumables & Accessories), Test Type (Imaging Test, Blood Test, Biopsy, and Others), Cancer Type (Pharyngeal Cancer and Laryngeal Cancer), Stages (Stage 0, Stage I, Stage II, Stage III and Stage IV), Age Group (30-65, 65 and above, 21-29 and Below 21), End User (Hospitals, Associated Labs, Independent Diagnostic Laboratories, Diagnostic Imaging Centres, Cancer Research Institutes and Others) and By Distribution Channel (Direct Tender and Retail Sales), Country (China, Japan, South Korea, India, Thailand, Singapore, Indonesia, Malaysia, Philippines, Australia, Vietnam, Rest of Asia-Pacific), Industry Trends and Forecast to 2030.

Initiatives by the government and other authorities for life sciences and funding

Increasing diagnostic products for throat cancer

Market Players:

Some of the key market players in Asia-Pacific throat cancer diagnostics market are listed below:

F. Hoffmann-La Roche Ltd.

FUJIFILM Corporation

Thermo Fisher Scientific Inc.

CANON MEDICAL SYSTEMS CORPORATION

Koninklijke Philips N.V.

Merck KGaA

General Electric Company

Illumina

Agilent Technologies, Inc.

Bio-Rad Laboratories, Inc.

Abbott

QIAGEN

Siemens Healthcare GmbH

Myriad Genetics Inc.

Quest Diagnostics Incorporated

Hologic

Time Medical Holding.

Medonica Co. LTD

MinFound Medical Systems Co., Ltd

PlexBio.

Beijing O&D Biotech Co., Ltd.

1 INTRODUCTION 46

1.1 OBJECTIVES OF THE STUDY 46
1.2 MARKET DEFINITION 46
1.3 OVERVIEW OF THE ASIA PACIFIC THROAT CANCER DIAGNOSTICS MARKET 46
1.4 LIMITATIONS 48
1.5 MARKETS COVERED 48

2 MARKET SEGMENTATION 51

2.1 MARKETS COVERED 51
2.2 GEOGRAPHICAL SCOPE 52
2.3 YEARS CONSIDERED FOR THE STUDY 53
2.4 CURRENCY AND PRICING 53
2.5 DBMR TRIPOD DATA VALIDATION MODEL 54
2.6 MULTIVARIATE MODELLING 57
2.7 PRODUCT TYPE LIFELINE CURVE 57
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 58
2.9 DBMR MARKET POSITION GRID 59
2.10 MARKET END USER COVERAGE GRID 60
2.11 VENDOR SHARE ANALYSIS 61
2.12 SECONDARY SOURCES 62
2.13 ASSUMPTIONS 62

3 EXECUTIVE SUMMARY 63

4 PREMIUM INSIGHTS 66

4.1 PESTEL ANALYSIS 67
4.2 PORTER'S FIVE FORCES 68

5 INDUSTRY INSIGHTS 69

6 EPIDEMIOLOGY 70

7 ASIA PACIFIC THROAT CANCER DIAGNOSTICS MARKET, REGULATIONS 71

7.1 REGULATORY SCENARIO IN THE U.S 71
7.2 REGULATORY SCENARIO IN AUSTRALIA 72
7.3 REGULATORY SCENARIO IN JAPAN 72
7.4 REGULATORY SCENARIO IN CHINA 72

8 MARKET OVERVIEW 74

8.1 DRIVERS 76
- 8.1.1 GROWING PREVALENCE OF THROAT CANCER 76
- 8.1.2 NOVEL TECHNOLOGICAL ADVANCEMENTS IN THROAT CANCER DIAGNOSTICS 76
- 8.1.3 INCREASE IN AWARENESS REGARDING THROAT CANCER 77
8.2 RESTRAINTS 77
- 8.2.1 LATE DIAGNOSIS AND POOR PROGNOSIS OF THROAT CANCER 77
- 8.2.2 HIGH COST FOR THE INSTALLATION OF DIAGNOSTIC DEVICES. 77
8.3 OPPORTUNITIES 78
- 8.3.1 RISE IN HEALTHCARE EXPENDITURE FOR CANCER DIAGNOSIS AND TREATMENT 78
- 8.3.2 GOVERNMENT INITIATIVES TOWARD CANCER DIAGNOSTICS 79
- 8.3.3 STRATEGIC INITIATIVES BY MARKET PLAYERS 79
8.4 CHALLENGES 80
- 8.4.1 INCREASED COST, SAFETY, AND CONVENIENCE ISSUES 80
- 8.4.2 LACK OF SKILLED AND CERTIFIED PROFESSIONALS 80

9 ASIA PACIFIC THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE 81

9.1 OVERVIEW 82
9.2 INSTRUMENTS 85
- 9.2.1 PATHOLOGY-BASED INSTRUMENTS 86
  - 9.2.1.1 PCR INSTRUMENTS 86
  - 9.2.1.2 SLIDE STAINING SYSTEMS 86
  - 9.2.1.3 TISSUE PROCESSING SYSTEMS 87
  - 9.2.1.4 CELL PROCESSORS 87
  - 9.2.1.5 OTHER PATHOLOGY-BASED INSTRUMENTS 87
- 9.2.2 IMAGING INSTRUMENTS 87
  - 9.2.2.1 ULTRASOUND SYSTEMS 87
  - 9.2.2.2 CT SYSTEMS 87
  - 9.2.2.3 MRI SYSTEMS 87
  - 9.2.2.4 OTHERS 88
- 9.2.3 BIOPSY INSTRUMENTS 88
- 9.2.4 OTHERS 88
9.3 CONSUMABLES & ACCESSORIES 88
- 9.3.1 KITS 89
  - 9.3.1.1 PCR KITS 89
  - 9.3.1.2 DNA POLYMERASE KITS 89
  - 9.3.1.3 NUCLEIC ACID ISOLATION KITS 89
  - 9.3.1.4 OTHERS 90
- 9.3.2 REAGENTS 90
  - 9.3.2.1 ASSAYS 90
  - 9.3.2.2 BUFFERS 90
  - 9.3.2.3 PRIMERS 90
  - 9.3.2.4 OTHERS 90
- 9.3.3 PROBES 90
- 9.3.4 OTHER CONSUMABLES 90

10 ASIA PACIFIC THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE 91

10.1 OVERVIEW 92
10.2 IMAGING TEST 95
- 10.2.1 COMPUTED TOMOGRAPHY (CT) SCAN 96
- 10.2.2 MRI 96
- 10.2.3 CHEST X-RAY 96
- 10.2.4 POSITRON EMISSION TOMOGRAPHY (PET) SCAN 96
- 10.2.5 OTHERS 96
10.3 BLOOD TEST 96
- 10.3.1 BLOOD CHEMISTRY TESTS 98
- 10.3.2 COMPLETE BLOOD COUNT (CBC) 98
- 10.3.3 OTHERS 98
10.4 BIOPSY 98
- 10.4.1 ENDOSCOPIC BIOPSY 99
- 10.4.2 FINE NEEDLE ASPIRATION (FNA) BIOPSY 99
- 10.4.3 OTHERS 99
10.5 OTHERS 100

11 ASIA PACIFIC THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE 101

11.1 OVERVIEW 102
11.2 PHARYNGEAL CANCER 105
- 11.2.1 NASOPHARYNGEAL CANCER 106
- 11.2.2 OROPHARYNGEAL CANCER 106
- 11.2.3 HYPOPHARYNGEAL CANCER 106
11.3 LARYNGEAL CANCER 107

12 ASIA PACIFIC THROAT CANCER DIAGNOSTICS MARKET, BY STAGES 108

12.1 OVERVIEW 109
12.2 STAGE III 112
12.3 STAGE II 112
12.4 STAGE IV 113
12.5 STAGE I 114
12.6 STAGE 0 115

13 ASIA PACIFIC THROAT CANCER DIAGNOSTICS MARKET, BY AGE 116

13.1 OVERVIEW 117
13.2 30-65 120
13.3 65 AND ABOVE 121
13.4 21-29 121
13.5 BELOW 21 122

14 ASIA PACIFIC THROAT CANCER DIAGNOSTICS MARKET, BY END USER 123

14.1 OVERVIEW 124
14.2 HOSPITALS 127
14.3 ASSOCIATED LABS 127
14.4 INDEPENDENT DIAGNOSTIC LABORATORIES 128
14.5 DIAGNOSTIC IMAGING CENTERS 129
14.6 CANCER RESEARCH INSTITUTES 130
14.7 OTHERS 131

15 ASIA PACIFIC THROAT CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL 132

15.1 OVERVIEW 133
15.2 DIRECT TENDER 136
15.3 RETAIL SALES 137

16 ASIA PACIFIC THROAT CANCER DIAGNOSTICS MARKET, BY REGION 138

16.1 ASIA-PACIFIC 139
- 16.1.1 CHINA 150
- 16.1.2 JAPAN 155
- 16.1.3 SOUTH KOREA 160
- 16.1.4 INDIA 165
- 16.1.5 THAILAND 170
- 16.1.6 SINGAPORE 175
- 16.1.7 INDONESIA 180
- 16.1.8 MALAYSIA 185
- 16.1.9 PHILIPPINES 190
- 16.1.10 AUSTRALIA 195
- 16.1.11 VIETNAM 200
- 16.1.12 REST OF ASIA-PACIFIC 205

17 ASIA PACIFIC THROAT CANCER DIAGNOSTICS MARKET, COMPANY LANDSCAPE 206

17.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC 206

18 SWOT ANALYSIS 207

19 COMPANY PROFILE 208

19.1 F. HOFFMANN- LA ROCHE LTD 208
- 19.1.1 COMPANY SNAPSHOT 208
- 19.1.2 REVENUE ANALYSIS 208
- 19.1.3 COMPANY SHARE ANALYSIS 209
- 19.1.4 PRODUCT PORTFOLIO 209
- 19.1.5 RECENT DEVELOPMENT 209
19.2 FUJIFILM CORPORATION 210
- 19.2.1 COMPANY SNAPSHOT 210
- 19.2.2 REVENUE ANALYSIS 210
- 19.2.3 COMPANY SHARE ANALYSIS 211
- 19.2.4 PRODUCT PORTFOLIO 211
- 19.2.5 RECENT DEVELOPMENT 211
19.3 THERMO FISHER SCIENTIFIC INC. 212
- 19.3.1 COMPANY SNAPSHOT 212
- 19.3.2 REVENUE ANALYSIS 212
- 19.3.3 COMPANY SHARE ANALYSIS 213
- 19.3.4 PRODUCT PORTFOLIO 213
- 19.3.5 RECENT DEVELOPMENTS 213
19.4 CANON MEDICAL SYSTEMS CORPORATION 214
- 19.4.1 COMPANY SNAPSHOT 214
- 19.4.2 REVENUE ANALYSIS 214
- 19.4.3 COMPANY SHARE ANALYSIS 215
- 19.4.4 PRODUCT PORTFOLIO 215
- 19.4.5 RECENT DEVELOPMENT 215
19.5 KONINKLIJKE PHILIPS N.V. 216
- 19.5.1 COMPANY SNAPSHOT 216
- 19.5.2 REVENUE ANALYSIS 216
- 19.5.3 COMPANY SHARE ANALYSIS 217
- 19.5.4 PRODUCT PORTFOLIO 217
- 19.5.5 RECENT DEVELOPMENT 218
19.6 ABBOTT 219
- 19.6.1 COMPANY SNAPSHOT 219
- 19.6.2 REVENUE ANALYSIS 219
- 19.6.3 PRODUCT PORTFOLIO 220
- 19.6.4 RECENT DEVELOPMENTS 220
19.7 AGILENT TECHNOLOGIES, INC. 221
- 19.7.1 COMPANY SNAPSHOT 221
- 19.7.2 REVENUE ANALYSIS 221
- 19.7.3 PRODUCT PORTFOLIO 222
- 19.7.4 RECENT DEVELOPMENT 222
19.8 BD 223
- 19.8.1 COMPANY SNAPSHOT 223
- 19.8.2 REVENUE ANALYSIS 223
- 19.8.3 PRODUCT PORTFOLIO 224
- 19.8.4 RECENT DEVELOPMENTS 224
19.9 BEIJING O&D BIOTECH CO., LTD. 225
- 19.9.1 COMPANY SNAPSHOT 225
- 19.9.2 PRODUCT PORTFOLIO 225
- 19.9.3 RECENT DEVELOPMENT 225
19.10 BIO-RAD LABORATORIES, INC. 226
- 19.10.1 COMPANY SNAPSHOT 226
- 19.10.2 REVENUE ANALYSIS 226
- 19.10.3 PRODUCT PORTFOLIO 227
- 19.10.4 RECENT DEVELOPMENT 227
19.11 FONAR CORP. 228
- 19.11.1 COMPANY SNAPSHOT 228
- 19.11.2 REVENUE ANALYSIS 228
- 19.11.3 PRODUCT PORTFOLIO 229
- 19.11.4 RECENT DEVELOPMENT 229
19.12 GE HEALTHCARE 230
- 19.12.1 COMPANY SNAPSHOT 230
- 19.12.2 REVENUE ANALYSIS 230
- 19.12.3 PRODUCT PORTFOLIO 231
- 19.12.4 RECENT DEVELOPMENT 231
19.13 HOLOGIC INC. 232
- 19.13.1 COMPANY SNAPSHOT 232
- 19.13.2 REVENUE ANALYSIS 232
- 19.13.3 PRODUCT PORTFOLIO 233
- 19.13.4 RECENT DEVELOPMENT 233
19.14 ILLUMINA, INC. 234
- 19.14.1 COMPANY SNAPSHOT 234
- 19.14.2 REVENUE ANALYSIS 234
- 19.14.3 PRODUCT PORTFOLIO 235
- 19.14.4 RECENT DEVELOPMENT 235
19.15 MEDONICA CO. LTD 236
- 19.15.1 COMPANY SNAPSHOT 236
- 19.15.2 PRODUCT PORTFOLIO 236
- 19.15.3 RECENT DEVELOPMENT 236
19.16 MERCK KGAA 237
- 19.16.1 COMPANY SNAPSHOT 237
- 19.16.2 REVENUE ANALYSIS 237
- 19.16.3 PRODUCT PORTFOLIO 238
- 19.16.4 RECENT DEVELOPMENT 238
19.17 MINFOUND MEDICAL SYSTEMS CO., LTD 239
- 19.17.1 COMPANY SNAPSHOT 239
- 19.17.2 PRODUCT PORTFOLIO 239
- 19.17.3 RECENT DEVELOPMENT 239
19.18 MYRIAD GENETICS, INC. 240
- 19.18.1 COMPANY SNAPSHOT 240
- 19.18.2 REVENUE ANALYSIS 240
- 19.18.3 PRODUCT PORTFOLIO 241
- 19.18.4 RECENT DEVELOPMENT 241
19.19 PLEXBIO 242
- 19.19.1 COMPANY SNAPSHOT 242
- 19.19.2 PRODUCT PORTFOLIO 242
- 19.19.3 RECENT DEVELOPMENT 242
19.20 QIAGEN 243
- 19.20.1 COMPANY SNAPSHOT 243
- 19.20.2 REVENUE ANALYSIS 243
- 19.20.3 PRODUCT PORTFOLIO 244
- 19.20.4 RECENT DEVELOPMENT 244
19.21 QUEST DIAGNOSTICS INCORPORATED 245
- 19.21.1 COMPANY SNAPSHOT 245
- 19.21.2 REVENUE ANALYSIS 245
- 19.21.3 PRODUCT PORTFOLIO 246
- 19.21.4 RECENT DEVELOPMENT 246
19.22 SIEMENS HEALTHCARE GMBH 247
- 19.22.1 COMPANY SNAPSHOT 247
- 19.22.2 REVENUE ANALYSIS 247
- 19.22.3 PRODUCT PORTFOLIO 248
- 19.22.4 RECENT DEVELOPMENT 248

19.23 STERNMED GMBH 249
- 19.23.1 COMPANY SNAPSHOT 249
- 19.23.2 PRODUCT PORTFOLIO 249
- 19.23.3 RECENT DEVELOPMENT 249
19.24 TIME MEDICAL HOLDING. 250
- 19.24.1 COMPANY SNAPSHOT 250
- 19.24.2 PRODUCT PORTFOLIO 250
- 19.24.3 RECENT DEVELOPMENT 250

20 QUESTIONNAIRE 251

21 RELATED REPORTS 255

LIST OF TABLES

TABLE 1 ASIA PACIFIC THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 64
TABLE 2 ASIA PACIFIC INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 65
TABLE 3 ASIA PACIFIC INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 66
TABLE 4 ASIA PACIFIC PATHOLOGY-BASED INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 66
TABLE 5 ASIA PACIFIC IMAGING INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 67
TABLE 6 ASIA PACIFIC CONSUMABLES & ACCESSORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 68
TABLE 7 ASIA PACIFIC CONSUMABLES AND ACCESSORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 69
TABLE 8 ASIA PACIFIC KITS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 69
TABLE 9 ASIA PACIFIC REAGENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 70
TABLE 10 ASIA PACIFIC THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 74
TABLE 11 ASIA PACIFIC IMAGING TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 75
TABLE 12 ASIA PACIFIC IMAGING TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 76
TABLE 13 ASIA PACIFIC BLOOD TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 77
TABLE 14 ASIA PACIFIC BLOOD TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 77
TABLE 15 ASIA PACIFIC BIOPSY IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 78
TABLE 16 ASIA PACIFIC BIOPSY IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 79
TABLE 17 ASIA PACIFIC OTHERS IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 80
TABLE 18 ASIA PACIFIC THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 84
TABLE 19 ASIA PACIFIC PHARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 85
TABLE 20 ASIA PACIFIC PHARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 86
TABLE 21 ASIA PACIFIC LARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 87
TABLE 22 ASIA PACIFIC THROAT CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION) 91
TABLE 23 ASIA PACIFIC STAGE III IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 92
TABLE 24 ASIA PACIFIC STAGE II IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 93
TABLE 25 ASIA PACIFIC STAGE IV IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 93
TABLE 26 ASIA PACIFIC STAGE I IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 94
TABLE 27 ASIA PACIFIC STAGE 0 IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 95
TABLE 28 ASIA PACIFIC THROAT CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 99
TABLE 29 ASIA PACIFIC 30-65 IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 100
TABLE 30 ASIA PACIFIC 65 AND ABOVE IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 101
TABLE 31 ASIA PACIFIC 21-29 IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 102
TABLE 32 ASIA PACIFIC BELOW 21 IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 102
TABLE 33 ASIA PACIFIC THROAT CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 106
TABLE 34 ASIA PACIFIC HOSPITAL IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 107
TABLE 35 ASIA PACIFIC ASSOCIATED LABS IN THROAT CANCER DIAGNOSTICS MARKET, 2021-2030 (USD MILLION) 108
TABLE 36 ASIA PACIFIC INDEPENDENT DIAGNOSTIC LABORATORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 108
TABLE 37 ASIA PACIFIC DIAGNOSTIC IMAGING CENTERS IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 109
TABLE 38 ASIA PACIFIC CANCER RESEARCH INSTITUTES IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 110
TABLE 39 ASIA PACIFIC OTHERS IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 111
TABLE 40 ASIA PACIFIC THROAT CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 115
TABLE 41 ASIA PACIFIC DIRECT TENDER IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 116
TABLE 42 ASIA PACIFIC RETAIL SALES IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 117
TABLE 43 ASIA-PACIFIC THROAT CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2021-2030 (USD MILLION) 124
TABLE 44 ASIA-PACIFIC THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 124
TABLE 45 ASIA-PACIFIC INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 124
TABLE 46 ASIA-PACIFIC PATHOLOGY-BASED INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 125
TABLE 47 ASIA-PACIFIC IMAGING INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 125
TABLE 48 ASIA-PACIFIC CONSUMABLES & ACCESSORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 125
TABLE 49 ASIA-PACIFIC KITS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 126
TABLE 50 ASIA-PACIFIC REAGENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 126
TABLE 51 ASIA-PACIFIC THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 126
TABLE 52 ASIA-PACIFIC IMAGING TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 127
TABLE 53 ASIA-PACIFIC BLOOD TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 127
TABLE 54 ASIA-PACIFIC BIOPSY IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 127
TABLE 55 ASIA-PACIFIC THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 127
TABLE 56 ASIA-PACIFIC PHARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 128
TABLE 57 ASIA-PACIFIC THROAT CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION) 128
TABLE 58 ASIA-PACIFIC THROAT CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 128
TABLE 59 ASIA-PACIFIC THROAT CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 129
TABLE 60 ASIA-PACIFIC THROAT CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 129
TABLE 61 CHINA THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 130
TABLE 62 CHINA INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 130
TABLE 63 CHINA PATHOLOGY-BASED INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 130
TABLE 64 CHINA IMAGING INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 131
TABLE 65 CHINA CONSUMABLES & ACCESSORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 131
TABLE 66 CHINA KITS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 131
TABLE 67 CHINA REAGENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 131
TABLE 68 CHINA THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 132
TABLE 69 CHINA IMAGING TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 132
TABLE 70 CHINA BLOOD TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 132
TABLE 71 CHINA BIOPSY IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 132
TABLE 72 CHINA THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 133
TABLE 73 CHINA PHARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 133
TABLE 74 CHINA THROAT CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION) 133
TABLE 75 CHINA THROAT CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 133
TABLE 76 CHINA THROAT CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 134
TABLE 77 CHINA THROAT CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 134
TABLE 78 JAPAN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 135
TABLE 79 JAPAN INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 135
TABLE 80 JAPAN PATHOLOGY-BASED INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 135
TABLE 81 JAPAN IMAGING INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 136
TABLE 82 JAPAN CONSUMABLES & ACCESSORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 136
TABLE 83 JAPAN KITS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 136
TABLE 84 JAPAN REAGENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 136
TABLE 85 JAPAN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 137
TABLE 86 JAPAN IMAGING TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 137
TABLE 87 JAPAN BLOOD TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 137
TABLE 88 JAPAN BIOPSY IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 137
TABLE 89 JAPAN THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 138
TABLE 90 JAPAN PHARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 138
TABLE 91 JAPAN THROAT CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION) 138
TABLE 92 JAPAN THROAT CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 138
TABLE 93 JAPAN THROAT CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 139
TABLE 94 JAPAN THROAT CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 139
TABLE 95 SOUTH KOREA THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 140
TABLE 96 SOUTH KOREA INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 140
TABLE 97 SOUTH KOREA PATHOLOGY-BASED INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 140
TABLE 98 SOUTH KOREA IMAGING INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 141
TABLE 99 SOUTH KOREA CONSUMABLES & ACCESSORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 141
TABLE 100 SOUTH KOREA KITS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 141
TABLE 101 SOUTH KOREA REAGENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 141
TABLE 102 SOUTH KOREA THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 142
TABLE 103 SOUTH KOREA IMAGING TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 142
TABLE 104 SOUTH KOREA BLOOD TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 142
TABLE 105 SOUTH KOREA BIOPSY IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 142
TABLE 106 SOUTH KOREA THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 143
TABLE 107 SOUTH KOREA PHARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 143
TABLE 108 SOUTH KOREA THROAT CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION) 143
TABLE 109 SOUTH KOREA THROAT CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 143
TABLE 110 SOUTH KOREA THROAT CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 144
TABLE 111 SOUTH KOREA THROAT CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 144
TABLE 112 INDIA THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 145
TABLE 113 INDIA INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 145
TABLE 114 INDIA PATHOLOGY-BASED INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 145
TABLE 115 INDIA IMAGING INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 146
TABLE 116 INDIA CONSUMABLES & ACCESSORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 146
TABLE 117 INDIA KITS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 146
TABLE 118 INDIA REAGENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 146
TABLE 119 INDIA THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 147
TABLE 120 INDIA IMAGING TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 147
TABLE 121 INDIA BLOOD TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 147
TABLE 122 INDIA BIOPSY IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 147
TABLE 123 INDIA THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 148
TABLE 124 INDIA PHARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 148
TABLE 125 INDIA THROAT CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION) 148
TABLE 126 INDIA THROAT CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 148
TABLE 127 INDIA THROAT CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 149
TABLE 128 INDIA THROAT CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 149
TABLE 129 THAILAND THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 150
TABLE 130 THAILAND INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 150
TABLE 131 THAILAND PATHOLOGY-BASED INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 150
TABLE 132 THAILAND IMAGING INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 151
TABLE 133 THAILAND CONSUMABLES & ACCESSORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 151
TABLE 134 THAILAND KITS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 151
TABLE 135 THAILAND REAGENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 151
TABLE 136 THAILAND THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 152
TABLE 137 THAILAND IMAGING TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 152
TABLE 138 THAILAND BLOOD TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 152
TABLE 139 THAILAND BIOPSY IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 152
TABLE 140 THAILAND THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 153
TABLE 141 THAILAND PHARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 153
TABLE 142 THAILAND THROAT CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION) 153
TABLE 143 THAILAND THROAT CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 153
TABLE 144 THAILAND THROAT CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 154
TABLE 145 THAILAND THROAT CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 154
TABLE 146 SINGAPORE THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 155
TABLE 147 SINGAPORE INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 155
TABLE 148 SINGAPORE PATHOLOGY-BASED INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 155
TABLE 149 SINGAPORE IMAGING INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 156
TABLE 150 SINGAPORE CONSUMABLES & ACCESSORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 156
TABLE 151 SINGAPORE KITS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 156
TABLE 152 SINGAPORE REAGENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 156
TABLE 153 SINGAPORE THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 157
TABLE 154 SINGAPORE IMAGING TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 157
TABLE 155 SINGAPORE BLOOD TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 157
TABLE 156 SINGAPORE BIOPSY IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 157
TABLE 157 SINGAPORE THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 158
TABLE 158 SINGAPORE PHARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 158
TABLE 159 SINGAPORE THROAT CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION) 158
TABLE 160 SINGAPORE THROAT CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 158
TABLE 161 SINGAPORE THROAT CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 159
TABLE 162 SINGAPORE THROAT CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 159
TABLE 163 INDONESIA THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 160
TABLE 164 INDONESIA INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 160
TABLE 165 INDONESIA PATHOLOGY-BASED INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 160
TABLE 166 INDONESIA IMAGING INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 161
TABLE 167 INDONESIA CONSUMABLES & ACCESSORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 161
TABLE 168 INDONESIA KITS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 161
TABLE 169 INDONESIA REAGENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 161
TABLE 170 INDONESIA THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 162
TABLE 171 INDONESIA IMAGING TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 162
TABLE 172 INDONESIA BLOOD TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 162
TABLE 173 INDONESIA BIOPSY IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 162
TABLE 174 INDONESIA THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 163
TABLE 175 INDONESIA PHARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 163
TABLE 176 INDONESIA THROAT CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION) 163
TABLE 177 INDONESIA THROAT CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 163
TABLE 178 INDONESIA THROAT CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 164
TABLE 179 INDONESIA THROAT CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 164
TABLE 180 MALAYSIA THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 165
TABLE 181 MALAYSIA INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 165
TABLE 182 MALAYSIA PATHOLOGY-BASED INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 165
TABLE 183 MALAYSIA IMAGING INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 166

LIST OF FIGURES

FIGURE 1 ASIA PACIFIC THROAT CANCER DIAGNOSTICS MARKET: SEGMENTATION 29
FIGURE 2 ASIA PACIFIC THROAT CANCER DIAGNOSTICS MARKET: DATA TRIANGULATION 32
FIGURE 3 ASIA PACIFIC THROAT CANCER DIAGNOSTICS MARKET: DROC ANALYSIS 33
FIGURE 4 ASIA PACIFIC THROAT CANCER DIAGNOSTICS MARKET: ASIA PACIFIC VS REGIONAL MARKET ANALYSIS 34
FIGURE 5 ASIA PACIFIC THROAT CANCER DIAGNOSTICS MARKET: COMPANY RESEARCH ANALYSIS 34
FIGURE 6 ASIA PACIFIC THROAT CANCER DIAGNOSTICS MARKET: INTERVIEW DEMOGRAPHICS 36
FIGURE 7 ASIA PACIFIC THROAT CANCER DIAGNOSTICS MARKET: DBMR MARKET POSITION GRID 37
FIGURE 8 ASIA PACIFIC THROAT CANCER DIAGNOSTICS MARKET: MARKET END USER COVERAGE GRID 38
FIGURE 9 ASIA PACIFIC THROAT CANCER DIAGNOSTICS MARKET: VENDOR SHARE ANALYSIS 39
FIGURE 10 ASIA PACIFIC THROAT CANCER DIAGNOSTICS MARKET: SEGMENTATION 43
FIGURE 11 THE INCREASE IN THE AWARENESS ABOUT THROAT CANCER IS EXPECTED TO DRIVE THE ASIA PACIFIC THROAT CANCER DIAGNOSTICS MARKET GROWTH IN THE FORECAST PERIOD 44
FIGURE 12 THE INSTRUMENT TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA PACIFIC THROAT CANCER DIAGNOSTICS MARKET IN 2023 & 2030 44
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE ASIA PACIFIC THROAT CANCER DIAGNOSTICS MARKET 53
FIGURE 14 ASIA PACIFIC THROAT CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE, 2022 60
FIGURE 15 ASIA PACIFIC THROAT CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE, 2023-2030 (USD MILLION) 61
FIGURE 16 ASIA PACIFIC THROAT CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE, CAGR (2023-2030) 61
FIGURE 17 ASIA PACIFIC THROAT CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE, LIFELINE CURVE 62
FIGURE 18 ASIA PACIFIC THROAT CANCER DIAGNOSTICS MARKET: BY TEST TYPE, 2022 70
FIGURE 19 ASIA PACIFIC THROAT CANCER DIAGNOSTICS MARKET: BY TEST TYPE, 2023-2030 (USD MILLION) 71
FIGURE 20 ASIA PACIFIC THROAT CANCER DIAGNOSTICS MARKET: BY TEST TYPE, CAGR (2023-2030) 71
FIGURE 21 ASIA PACIFIC THROAT CANCER DIAGNOSTICS MARKET: BY TEST TYPE, LIFELINE CURVE 72
FIGURE 22 ASIA PACIFIC THROAT CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, 2022 80
FIGURE 23 ASIA PACIFIC THROAT CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, 2023-2030 (USD MILLION) 81
FIGURE 24 ASIA PACIFIC THROAT CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, CAGR (2023-2030) 81
FIGURE 25 ASIA PACIFIC THROAT CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, LIFELINE CURVE 82
FIGURE 26 ASIA PACIFIC THROAT CANCER DIAGNOSTICS MARKET: BY STAGES, 2022 87
FIGURE 27 ASIA PACIFIC THROAT CANCER DIAGNOSTICS MARKET: BY STAGES, 2023-2030 (USD MILLION) 88
FIGURE 28 ASIA PACIFIC THROAT CANCER DIAGNOSTICS MARKET: BY STAGES, CAGR (2023-2030) 88
FIGURE 29 ASIA PACIFIC THROAT CANCER DIAGNOSTICS MARKET: BY STAGES, LIFELINE CURVE 89
FIGURE 30 ASIA PACIFIC THROAT CANCER DIAGNOSTICS MARKET: BY AGE GROUP, 2022 95
FIGURE 31 ASIA PACIFIC THROAT CANCER DIAGNOSTICS MARKET: BY AGE GROUP, 2023-2030 (USD MILLION) 96
FIGURE 32 ASIA PACIFIC THROAT CANCER DIAGNOSTICS MARKET: BY AGE GROUP, CAGR (2023-2030) 96
FIGURE 33 ASIA PACIFIC THROAT CANCER DIAGNOSTICS MARKET: BY AGE GROUP, LIFELINE CURVE 97
FIGURE 34 ASIA PACIFIC THROAT CANCER DIAGNOSTICS MARKET: BY END USER, 2022 102
FIGURE 35 ASIA PACIFIC THROAT CANCER DIAGNOSTICS MARKET: BY END USER, 2023-2030 (USD MILLION) 103
FIGURE 36 ASIA PACIFIC THROAT CANCER DIAGNOSTICS MARKET: BY END USER, CAGR (2023-2030) 103
FIGURE 37 ASIA PACIFIC THROAT CANCER DIAGNOSTICS MARKET: BY END USER, LIFELINE CURVE 104
FIGURE 38 ASIA PACIFIC THROAT CANCER DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, 2022 111
FIGURE 39 ASIA PACIFIC THROAT CANCER DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION) 112
FIGURE 40 ASIA PACIFIC THROAT CANCER DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030) 112
FIGURE 41 ASIA PACIFIC THROAT CANCER DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE 113
FIGURE 42 ASIA-PACIFIC THROAT CANCER DIAGNOSTICS MARKET: SNAPSHOT (2022) 118
FIGURE 43 ASIA-PACIFIC THROAT CANCER DIAGNOSTICS MARKET: BY COUNTRY (2022) 120

FIGURE 44 ASIA-PACIFIC THROAT CANCER DIAGNOSTICS MARKET: BY COUNTRY (2023 & 2030) 120
FIGURE 45 ASIA-PACIFIC THROAT CANCER DIAGNOSTICS MARKET: BY COUNTRY (2023 & 2030) 121
FIGURE 46 ASIA-PACIFIC THROAT CANCER DIAGNOSTICS MARKET: PRODUCT TYPE (2023-2030) 121
FIGURE 47 ASIA PACIFIC THROAT CANCER DIAGNOSTICS MARKET: COMPANY SHARE 2022 (%) 184